单位:[1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Hubei, Peoples R China华中科技大学同济医学院附属同济医院放射科[2]Fujian Med Univ Union Hosp, Dept Radiol, Fuzhou, Fujian, Peoples R China
IntroductionThe orthotopic xenograft tumors of human glioma stem cells (GSCs) is a recent glioma model with genotype and phenotypic characteristics close to human gliomas. This study aimed to explore the imaging and immunohistochemical characteristics of GSCs gliomas. MethodsThe rats underwent MRI and F-18-FDG PET scan in 6(th)-8(th) weeks after GSCs implantation. The MRI morphologic, DWI and PET features of the tumor lesions were assessed. In addition, the immunohistochemical features of the tumor tissues were further analyzed. ResultsTwenty-five tumor lesions were identified in 20 tumor-bearing rats. On structural MRI, the average tumor size was 30.04 +/- 17.31mm(2), and the intensity was inhomogeneous in 76.00% (19/25) of the lesions. The proportion of the lesions mainly presented as solid, cystic and patchy tumor were 60.00% (15/25), 16.00% (4/25) and 24.00% (6/25), respectively. The boundary was unclear in 88.00% (22/25), and peritumoral mass effect was observed in 92.00% (23/25) of the lesions. On DWI, 80.00% (20/25) of the lesions showed increased intensity. Of the 14 lesions in the 11 rats underwent PET scan, 57.14% (8/14) showed increased FDG uptake. On immunohistochemical staining, the expression of Ki-67 was strong in all the lesions (51.67%+/- 11.82%). Positive EGFR and VEGF expression were observed in 64.71% (11/17) and 52.94% (9/17) of the rats, whereas MGMT and HIF-1 alpha showed negative expression in all the lesions. DiscussionGSC gliomas showed significant heterogeneity and invasiveness on imaging, and exhibited strong expression of Ki-67, partial expression of EGFR and VEGF, and weak expression of MGMT and HIF-1 alpha on immunohistochemical staining.
基金:
This work was supported by grants from National Natural
Science Foundation of China (Grant number: U22A20354,
81570462, 30870702 and 82001787), and Guidance Project of
Fujian Science and Technology Program (No. 2022Y0024).
第一作者单位:[1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Hubei, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Liu Yufei,Zhu Wenzhen,Zhu Hongquan,et al.Characterization of orthotopic xenograft tumor of glioma stem cells (GSCs) on MRI, PET and immunohistochemical staining[J].FRONTIERS IN ONCOLOGY.2022,12:doi:10.3389/fonc.2022.1085015.
APA:
Liu, Yufei,Zhu, Wenzhen,Zhu, Hongquan,Zhang, Jiaxuan,Zhang, Ju...&Jiang, Rifeng.(2022).Characterization of orthotopic xenograft tumor of glioma stem cells (GSCs) on MRI, PET and immunohistochemical staining.FRONTIERS IN ONCOLOGY,12,
MLA:
Liu, Yufei,et al."Characterization of orthotopic xenograft tumor of glioma stem cells (GSCs) on MRI, PET and immunohistochemical staining".FRONTIERS IN ONCOLOGY 12.(2022)